Biogenerator vs Annual Series GP Ulc Overbay 2026 Fund

Biogenerator vs Annual Series GP Ulc Overbay 2026 Fund

Biogenerator is a venture capital based in St Louis, Missouri, United States. Annual Series GP Ulc Overbay 2026 Fund is a venture capital based in Toronto across 1,800 portfolio companies. Sector focus diverges: Biogenerator concentrates on generalist deals and Annual Series GP Ulc Overbay 2026 Fund on Artificial Intelligence, Crypto Web3 and Fintech.

• Investor type: Biogenerator — Venture Capital; Annual Series GP Ulc Overbay 2026 Fund — Venture Capital
• Headquarters: Biogenerator — St Louis, Missouri, United States; Annual Series GP Ulc Overbay 2026 Fund — Toronto
• Portfolio companies: Biogenerator — not disclosed; Annual Series GP Ulc Overbay 2026 Fund — 1,800
• Sectors: Biogenerator — not disclosed; Annual Series GP Ulc Overbay 2026 Fund — Artificial Intelligence, Crypto Web3, Fintech

• BioGenerator — Venture Capital · St Louis, Missouri, United States · Biogenerator portfolio
• Annual Series GP ULC Overbay 2026 Fund — Venture Capital · Toronto · 1,800 tracked deals · Annual Series GP Ulc Overbay 2026 Fund portfolio

Similar investors

• Thomas J.A. Lavin
• Oren Netzer
• Michael B Collins
• Lee Moser
• Arie Benguigui
• TRCM Fund GP LLC
• Michael Collins
• James Danforth
• Roy Glasberg
• Private Credit Fund I GP, LP Dynamic

Investors like Biogenerator · Investors like Annual Series GP Ulc Overbay 2026 Fund · Biogenerator co-investors · Full investor directory